Your browser doesn't support javascript.
loading
Targeting interleukin-2 to the bone marrow stroma for therapy of acute myeloid leukemia relapsing after allogeneic hematopoietic stem cell transplantation.
Schliemann, Christoph; Gutbrodt, Katrin L; Kerkhoff, Andrea; Pohlen, Michele; Wiebe, Stefanie; Silling, Gerda; Angenendt, Linus; Kessler, Torsten; Mesters, Rolf M; Giovannoni, Leonardo; Schäfers, Michael; Altvater, Bianca; Rossig, Claudia; Grünewald, Inga; Wardelmann, Eva; Köhler, Gabriele; Neri, Dario; Stelljes, Matthias; Berdel, Wolfgang E.
Afiliación
  • Schliemann C; Department of Medicine A, Hematology and Oncology, University Hospital Muenster, Muenster, Germany.
  • Gutbrodt KL; Department of Chemistry and Applied Biosciences, ETH Zurich, Zurich, Switzerland.
  • Kerkhoff A; Department of Medicine A, Hematology and Oncology, University Hospital Muenster, Muenster, Germany.
  • Pohlen M; Department of Medicine A, Hematology and Oncology, University Hospital Muenster, Muenster, Germany.
  • Wiebe S; Department of Medicine A, Hematology and Oncology, University Hospital Muenster, Muenster, Germany.
  • Silling G; Department of Medicine A, Hematology and Oncology, University Hospital Muenster, Muenster, Germany.
  • Angenendt L; Department of Medicine A, Hematology and Oncology, University Hospital Muenster, Muenster, Germany.
  • Kessler T; Department of Medicine A, Hematology and Oncology, University Hospital Muenster, Muenster, Germany.
  • Mesters RM; Department of Medicine A, Hematology and Oncology, University Hospital Muenster, Muenster, Germany.
  • Giovannoni L; Philogen SpA, Siena, Italy.
  • Schäfers M; Department of Nuclear Medicine, University Hospital Muenster, Muenster, Germany.
  • Altvater B; Department of Pediatric Hematology and Oncology, University Children's Hospital Muenster, Muenster, Germany.
  • Rossig C; Department of Pediatric Hematology and Oncology, University Children's Hospital Muenster, Muenster, Germany.
  • Grünewald I; Gerhard-Domagk-Institute for Pathology, University Hospital Muenster, Muenster, Germany.
  • Wardelmann E; Gerhard-Domagk-Institute for Pathology, University Hospital Muenster, Muenster, Germany.
  • Köhler G; Gerhard-Domagk-Institute for Pathology, University Hospital Muenster, Muenster, Germany. Institute of Pathology, General Hospital Fulda, Fulda, Germany.
  • Neri D; Department of Chemistry and Applied Biosciences, ETH Zurich, Zurich, Switzerland.
  • Stelljes M; Department of Medicine A, Hematology and Oncology, University Hospital Muenster, Muenster, Germany.
  • Berdel WE; Department of Medicine A, Hematology and Oncology, University Hospital Muenster, Muenster, Germany. berdel@uni-muenster.de.
Cancer Immunol Res ; 3(5): 547-56, 2015 May.
Article en En | MEDLINE | ID: mdl-25672398
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Médula Ósea / Leucemia Mieloide Aguda / Protocolos de Quimioterapia Combinada Antineoplásica / Trasplante de Células Madre Hematopoyéticas Tipo de estudio: Prognostic_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Immunol Res Año: 2015 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Médula Ósea / Leucemia Mieloide Aguda / Protocolos de Quimioterapia Combinada Antineoplásica / Trasplante de Células Madre Hematopoyéticas Tipo de estudio: Prognostic_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Immunol Res Año: 2015 Tipo del documento: Article País de afiliación: Alemania